SCHEMBL12426100

SCHEMBL12426100

Cc1ccccc1/C=C/CN

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TSHR P16473 3/20 0.46
TAAR1 Q96RJ0 1/20 0.43
RAB9A P51151 5/20 0.43
KDM4E B2RXH2 5/20 0.43
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
MEN1 O00255 1/20 0.42
PABPC1 P11940 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP1A2 P05177 2/20 0.40
TP53 P04637 1/20 0.40
CYP2D6 P10635 1/20 0.40
THPO P40225 1/20 0.40
HIF1A Q16665 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
ACHE P22303 1/20 0.38
PTGER1 P34995 1/20 0.36
PTGER4 P35408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16085821 1.00 ALDH1A1 (0.46) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL17212928 0.83 TAAR1 (0.36) ALDH1A1TSHRTAAR1CYP1A2PTGER1
SCHEMBL6090315 0.80 TAAR1 (0.42) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL2313488 0.80 ALDH1A1 (0.48) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL1276606 0.80 ALDH1A1 (0.48) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL29373824 0.80 ALDH1A1 (0.48) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL9477274 0.78 ALDH1A1 (0.46) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL7292415 0.78 ALDH1A1 (0.46) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL11051471 0.78 ALDH1A1 (0.46) ALDH1A1TSHRTAAR1RAB9AKDM4E
SCHEMBL19661446 0.78 ALDH1A1 (0.46) ALDH1A1TSHRTAAR1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273040-B2 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels MERCK SHARP & DOHME CORP. (US) 2016-03-01 US disclosed
US-9260382-B2 Methods of reducing virulence in bacteria UWM RESEARCH FOUNDATION (US) 2016-02-16 US disclosed
US-9260382-B2 Methods of reducing virulence in bacteria UWM RESEARCH FOUNDATION (US) 2016-02-16 US disclosed
US-20140303143-A1 BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME LLC 2014-10-09 US disclosed
WO-2013063459-A1 BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2013-05-02 WO disclosed
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA DUKE UNIVERSITY (US) 2012-12-20 US disclosed
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA DUKE UNIVERSITY (US) 2012-12-20 US disclosed
WO-2011103189-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA UWM RESEARCH FOUNDATION, INC. (US) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA PGLS, RRS1, MRPL21 ALDH1A1 4049/4885TSHR 1669/4885TAAR1 4085/4885
US-20140303143-A1 BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS SCN7A, SCN1A, CACNA1E ALDH1A1 910/4885TSHR 1878/4885TAAR1 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.